Kempharm, inc (KMPH)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14
Assets
Cash and cash equivalents

2,356

3,217

6,518

7,308

13,438

18,409

1,788

16,497

8,750

10,871

7,829

12,386

12,880

16,762

20,846

27,510

77,333

32,318

59,009

64,223

10,269

10,255

Restricted cash

-

-

-

-

-

-

1,100

1,100

1,100

-

1,100

1,100

1,100

1,100

1,100

1,100

-

0

-

-

-

-

Marketable securities

-

-

-

-

-

3,260

11,239

11,702

25,873

31,358

37,412

41,107

48,243

51,003

42,679

55,134

33,668

19,002

-

-

-

-

Accounts and other receivables

2,265

1,865

1,638

-

-

140

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trade date receivables

-

-

-

-

-

-

0

0

1,511

2,005

2,503

0

0

5,003

-

-

-

0

-

-

-

-

Prepaid expenses and other current assets

890

1,552

528

1,332

1,873

1,912

2,610

1,610

1,845

1,662

1,354

771

795

489

636

824

386

2,758

607

607

53

23

Total current assets

5,511

6,634

8,684

8,640

15,311

23,721

16,737

30,909

39,079

45,896

50,198

55,364

63,018

74,357

65,261

84,568

111,387

54,078

59,616

64,830

10,322

10,278

Debt issuance costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,215

1,301

1,384

1,468

Property and equipment, net

1,210

1,471

1,541

1,613

1,688

1,753

1,817

1,841

1,924

2,004

2,086

2,148

2,201

1,970

1,456

1,105

443

403

386

352

354

352

Operating lease right-of-use assets

1,451

1,537

1,649

1,718

1,785

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

-

-

-

-

-

-

0

0

0

3,250

6,717

11,215

10,162

8,200

27,355

18,850

-

0

-

-

-

-

Restricted cash

186

338

490

490

528

710

-

-

-

1,100

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

527

527

526

548

555

562

183

1,250

1,646

206

313

321

260

360

472

111

109

109

199

56

2,058

1,616

Total assets

8,885

10,507

12,890

13,009

19,867

26,746

18,737

34,000

42,649

52,456

59,314

69,048

75,641

84,887

94,544

104,634

111,939

54,590

61,416

66,539

14,118

13,714

Liabilities and stockholders' deficit
Accounts payable and accrued expenses

6,415

4,911

3,095

7,862

8,178

8,342

14,677

13,967

10,177

7,875

6,355

6,303

4,584

6,444

5,599

5,356

4,178

4,906

4,031

4,878

4,000

3,096

Current portion of convertible notes

68,606

-

6,718

6,497

6,370

3,333

3,333

3,333

3,333

3,333

-

-

-

0

0

1,932

1,649

1,369

1,097

-

-

325

Current portion of term notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

2,041

1,632

-

-

482

Current portion of capital lease obligation

-

-

-

-

-

214

210

190

187

189

180

177

162

157

105

103

18

26

32

32

32

32

Current portion of operating lease liabilities

301

284

369

394

395

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

237

236

227

222

229

115

103

113

113

112

112

112

62

41

-

-

-

0

-

-

-

-

Total current liabilities

75,559

5,431

10,409

14,975

15,172

12,004

18,323

17,603

13,810

11,509

6,647

6,592

4,808

6,642

5,704

7,391

5,845

8,342

6,792

4,910

4,032

3,935

Convertible notes, less current portion, net

-

77,343

70,553

75,551

75,373

78,105

87,171

86,845

89,788

89,398

92,341

91,950

91,560

91,170

90,779

90,389

90,086

7,412

7,708

7,550

7,393

7,235

Term notes, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

11,118

11,562

11,326

11,089

10,853

Derivative and warrant liability

44

120

335

1,686

1,665

2,118

7,420

11,888

17,450

7,709

6,999

8,311

11,834

4,618

7,342

6,043

27,479

37,839

41,097

39,279

17,728

15,966

Capital lease obligation, less current portion

-

-

-

-

-

396

451

466

515

562

-

-

-

657

-

-

-

-

3

11

18

26

Operating lease liabilities, less current portion

1,836

1,901

1,976

2,048

2,142

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

121

168

237

296

351

689

717

743

769

794

1,427

1,472

1,368

496

521

478

11

0

-

-

-

-

Total liabilities

77,560

84,963

83,510

94,556

94,703

93,312

114,082

117,545

122,332

109,972

107,414

108,325

109,570

103,583

104,346

104,301

123,421

64,711

67,162

63,076

40,260

38,015

Commitments and contingencies (Note D)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

Total Redeemable Convertible Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24,207

Total Redeemable Convertible Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,210

-

Stockholders’ deficit:
Preferred stock

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.0001 par value, 250,000,000 shares authorized, 56,760,111 shares issued and outstanding as of March 31, 2020 (unaudited); 36,350,785 shares issued and outstanding as of December 31, 2019

6

4

3

3

3

3

2

2

2

1

1

1

1

1

1

1

1

1

3

3

2

-

Additional paid-in capital

182,787

171,254

169,054

161,190

158,644

154,623

120,662

117,391

111,260

107,209

106,059

104,901

103,732

102,643

101,601

98,322

96,275

94,702

89,873

89,337

1,780

1,652

Accumulated deficit

-251,468

-245,714

-239,677

-242,740

-233,483

-221,192

-216,009

-200,938

-190,945

-164,726

-154,160

-144,179

-137,662

-121,340

-111,404

-97,990

-107,758

-104,824

-95,622

-85,877

-56,134

-50,160

Total stockholders' deficit

-68,675

-74,456

-70,620

-81,547

-74,836

-66,566

-95,345

-83,545

-79,683

-57,516

-48,100

-39,277

-33,929

-18,696

-9,802

333

-11,482

-10,121

-5,746

3,463

-54,352

-48,508

Total liabilities and stockholders' deficit

8,885

10,507

12,890

13,009

19,867

26,746

18,737

34,000

42,649

52,456

59,314

69,048

75,641

84,887

94,544

104,634

111,939

54,590

61,416

66,539

14,118

13,714